Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ZVRA
#2506
Zevra Therapeutics, Inc. Common Stock
8.930
0
+0.68%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+0.68%
Monthly Change
0.00%
6 month change
-16.07%
Year Change
-16.07%
Previous Close
8.870
0
Open
8.930
0
Bid
Ask
Low
8.930
0
High
8.930
0
Volume
101
Markets
US Stock Market
Healthcare
ZVRA
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
News
Aclaris Therapeutics (ACRS) Reports Q4 Loss, Lags Revenue Estimates
Ironwood Pharmaceuticals (IRWD) Reports Q4 Loss, Lags Revenue Estimates
Neil F. McFarlane, Zevra Therapeutics president, sells $125k in shares
Zevra Therapeutics CMO Quartel sells $40k in shares
Schafer Joshua, CCO of Zevra, sells $29,800 in ZVRA stock
Zevra Therapeutics CEO McFarlane sells $853k in shares
Zevra Therapeutics, Inc. (ZVRA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Zevra Stock: Asymmetric Risk-Reward Setup In Ultra-Rare Disease Market (ZVRA)
Zevra Therapeutics stock maintains Buy rating at H.C. Wainwright on expanded access deal
Zebra Pharmaceuticals at Guggenheim Conference: Strategic Growth in Rare Diseases
Zevra Therapeutics (ZVRA) Reports Q3 Loss, Lags Revenue Estimates
Top Stocks With Earnings This Week: Joby, IonQ, AMD and More - Palantir Technologies (NASDAQ:PLTR)